Product image of Mycofenolaat Mofetil Mylan (Mycophenolate Mofetil) supplied by GNH India

Mycofenolaat Mofetil Mylan

Active Ingredient:
Mycophenolate Mofetil
Origin:
EU

Mycofenolaat Mofetil Mylan (Mycophenolate Mofetil)

Mycophenolate Mofetil, the active ingredient in Mycofenolaat Mofetil Mylan, is an immunosuppressant presented as an oral formulation for oral use. It is employed to prevent organ transplant rejection and to treat lupus nephritis in appropriate patient populations.

GNH India supplies Mycofenolaat Mofetil Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Manufacturer / TM Owner

Mylan Pharmaceuticals Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mycophenolate Mofetil is used in the management of immune‑mediated conditions, particularly in solid‑organ transplantation and autoimmune kidney disease.

  • Kidney transplant rejection: helps prevent acute and chronic rejection of the transplanted kidney.
  • Heart transplant rejection: reduces the risk of immune‑mediated damage to the transplanted heart.
  • Lupus nephritis: diminishes renal inflammation and proteinuria in patients with systemic lupus erythematosus.

How It Works

  • Mycophenolate Mofetil is a pro‑drug that is converted to mycophenolic acid, which selectively inhibits inosine monophosphate dehydrogenase (IMPDH). This enzyme is essential for de novo guanosine nucleotide synthesis in lymphocytes, leading to reduced proliferation of B and T cells and thereby suppressing the immune response.

Side Effects

Mycophenolate Mofetil may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Diarrhea: frequent loose stools.
  • Abdominal pain: cramping or discomfort.
  • Headache: occasional tension‑type headache.
  • Tremor: fine shaking of hands.
  • Increased susceptibility to infections: higher frequency of mild infections.

Serious or Rare Side Effects

  • Severe infection: opportunistic or life‑threatening infections.
  • Bone marrow suppression: leukopenia, anemia, or thrombocytopenia.
  • Liver toxicity: elevated transaminases or hepatitis.
  • Progressive multifocal leukoencephalopathy (PML): rare viral brain infection.
  • Malignancy risk: increased incidence of certain cancers.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.

Precautions & Warnings

Before initiating therapy, several safety considerations should be observed.

  • Monitor blood counts: regular CBC to detect leukopenia or anemia.
  • Monitor liver function: periodic LFTs to identify hepatotoxicity.
  • Avoid live vaccines: live attenuated vaccines may cause infection.
  • Use effective contraception: teratogenic potential requires pregnancy prevention.
  • Adjust dose in renal impairment: renal function may necessitate dose modification.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Mycophenolate Mofetil can interact with several medicines, affecting efficacy or safety.

Major Interactions (Avoid)

  • Azathioprine: additive bone‑marrow suppression.
  • Cyclosporine: increased mycophenolic acid exposure.
  • Tacrolimus: heightened immunosuppressive effect.
  • Live vaccines: risk of vaccine‑derived infection.
  • Strong CYP3A4 inducers (e.g., rifampin): reduced drug levels.

Moderate Interactions (Monitor Closely)

  • Antacids (aluminum or magnesium): may decrease absorption.
  • NSAIDs: potential for increased nephrotoxicity.
  • Non‑live vaccines: monitor immune response efficacy.

Frequently Asked Questions

Mycofenolaat Mofetil Mylan contains mycophenolate mofetil, an immunosuppressant used primarily to prevent rejection of transplanted organs such as kidneys, hearts, and livers, and to treat lupus nephritis by reducing kidney inflammation.

Mycophenolate mofetil is converted in the body to mycophenolic acid, which blocks the enzyme inosine monophosphate dehydrogenase. This inhibition stops the synthesis of guanosine nucleotides needed for lymphocyte proliferation, thereby dampening the immune response.

The specific dosage of Mycofenolaat Mofetil Mylan is determined by the prescribing clinician based on the patient’s condition, weight, renal function, and other individual factors. Only a qualified healthcare professional should set the dose.

The safety of mycophenolate mofetil in pregnancy and lactation is not well established. It is generally contraindicated in pregnancy due to potential teratogenic effects, and breastfeeding is not recommended unless the benefits outweigh the risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Compared with calcineurin inhibitors such as cyclosporine or tacrolimus, mycophenolate mofetil offers a different mechanism by targeting lymphocyte proliferation. It is often used in combination regimens and may have a more favorable side‑effect profile for certain patients, though individual response varies.

Store the product at room temperature, below 25 °C, in its original packaging. Protect it from moisture, excessive heat, and direct sunlight to maintain stability and potency.

Mycofenolaat Mofetil Mylan is taken orally, usually with food to reduce gastrointestinal upset. The tablet should be swallowed whole with a glass of water and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include severe infections, bone‑marrow suppression leading to low blood counts, liver toxicity, and rare but life‑threatening conditions such as progressive multifocal leukoencephalopathy or malignancies. Patients should be monitored closely for these events.

Patients with known hypersensitivity to mycophenolate mofetil or any component of the formulation, those with uncontrolled infections, and individuals who are pregnant or planning pregnancy should avoid this medication unless a specialist determines that benefits outweigh risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mycophenolate Mofetil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT